Covered recipient · General Payments record
ROBERT PARTOVY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,867.29
- Reported across 113 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $540.09 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $184.52 | 8 |
| Novo Nordisk AS | $174.80 | 8 |
| Phathom Pharmaceuticals, Inc. | $61.73 | 2 |
| Teva Pharmaceuticals USA, Inc. | $34.93 | 2 |
| ABBVIE INC. | $27.39 | 1 |
| Lilly USA, LLC | $24.68 | 1 |
| Alnylam Pharmaceuticals Inc. | $16.47 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.39 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105188104 | CMS |
| Alnylam Pharmaceuticals Inc. | $16.47 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125853087 | CMS |
| Amgen Inc. | $29.85 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117649576 | CMS |
| Amgen Inc. | $24.40 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115996380 | CMS |
| Amgen Inc. | $25.49 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115996385 | CMS |
| Amgen Inc. | $24.03 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115996390 | CMS |
| Amgen Inc. | $27.83 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117649578 | CMS |
| Amgen Inc. | $13.54 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117649580 | CMS |
| Amgen Inc. | $10.04 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117649582 | CMS |
| Amgen Inc. | $29.34 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117649584 | CMS |
| Lilly USA, LLC | $24.68 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135390903 | CMS |
| Novartis Pharmaceuticals Corporation | $15.57 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087218649 | CMS |
| Novo Nordisk Inc | $22.78 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096976933 | CMS |
| Novo Nordisk Inc | $23.63 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097132728 | CMS |
| Novo Nordisk Inc | $24.19 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096960806 | CMS |
| Novo Nordisk Inc | $24.67 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097827290 | CMS |
| Novo Nordisk Inc | $24.62 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096619136 | CMS |
| Novo Nordisk Inc | $5.06 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096622734 | CMS |
| Novo Nordisk Inc | $23.74 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097268098 | CMS |
| Novo Nordisk Inc | $26.11 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097451133 | CMS |
| Phathom Pharmaceuticals, Inc. | $34.31 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151106574 | CMS |
| Phathom Pharmaceuticals, Inc. | $27.42 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151106576 | CMS |
| Teva Pharmaceuticals USA, Inc. | $20.27 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151537453 | CMS |
| Teva Pharmaceuticals USA, Inc. | $14.66 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151537455 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.